Market revenue in 2024 | USD 36.8 million |
Market revenue in 2030 | USD 60.0 million |
Growth rate | 8.5% (CAGR from 2025 to 2030) |
Largest segment | Food & beverages |
Fastest growing segment | Dietary Supplements |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Food & Beverages, Dietary Supplements |
Key market players worldwide | Danone SA, Yakult Honsha Co Ltd, United Natural Foods Inc, Pfizer Inc, Sabinsa Corporation, Probiotical, Synbiotic Health, NUtech Ventures |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to synbiotic product market will help companies and investors design strategic landscapes.
Food & beverages was the largest segment with a revenue share of 94.57% in 2024. Horizon Databook has segmented the Brazil synbiotic product market based on food & beverages, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil is one of the fastest growing economies in the world, which has generated significant job and business opportunities in the country. The side-effect of this economic development, however, is that it has increased anxiety and depression levels among people owing to growing competition in the market.
According to a survey by the World Health Organization (WHO) published in 2017, Brazil held the fifth position in depression rates and topped in number cases of anxiety disorders in the world. These psychological disorders often disrupt the immune system of the body, destroy gut health, and further increase the susceptibility to depression.
In line with this, according to a scientific paper published by the Oxford University Press in June 2019, synbiotics may optimize the production of polyphenolic metabolites and act as therapeutic agents for inflammation-induced depression. Such findings are anticipated to bode well for the sales of synbiotic products in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil synbiotic product market, including forecasts for subscribers. This country databook contains high-level insights into Brazil synbiotic product market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account